Invokana is a Type II Diabetes drug that was introduced in 2013 by Johnson & Johnson under a license from Mitsubishi Tanabe Pharma who makes it. Invokana is the trade name for canagliflozin which, even though a powerful drug for improving glycemic control in patients, has been associated with adverse and potentially grave risks of diabetic ketoacidosis, kidney failure and other complications of the kidneys.
The FDA approved the drug in March 2013 even though five out of 15 experts voted against Invokana approval. In June 2015, Health Canada initiated a safety review of sodium-glucose cotransporter-2 SGLT2 inhibitors (such as Invokana) due to the risk of diabetic acidosis.
The lawyers in our directory of drug recall attorneys are investigating and litigating Invokana injury lawsuits of people who’ve suffered stroke, heart attacks, kidney failures or ketoacidosis as a result of using the drug. At least one basis for the Invokana lawsuits is that the manufacturer and marketers of this drug may have failed to provide the FDA and physicians important information about Invokana side effects and other potential risks of using it.
Our advice has always been aimed at ensuring safety through information that is aimed at helping someone avoid pharmaceutical injuries from defective and unsafe drugs. People who have been affected by Invokana, including people who suffer from diabetic ketoacidosis to kidney failure or families who have experienced the death of a loved one, may be entitled to compensation. If, unfortunately, you have been affected, then a lawsuit might be a good option for you to obtain justice and financial compensation.
Anyone who is or has been taking Invokana should check for symptoms such as difficulty in breathing, nausea, vomiting, abdominal pain, confusion and unusual fatigue which are all signs of ketoacidosis. If you do find that you have developed any of these complications, talk to an Invokana injury attorney in our directory for a free claim evaluation.